$0.96 Earnings Per Share Expected for Nu Skin Enterprises, Inc. (NUS) This Quarter

Share on StockTwits

Brokerages predict that Nu Skin Enterprises, Inc. (NYSE:NUS) will announce earnings per share (EPS) of $0.96 for the current quarter, according to Zacks. Four analysts have issued estimates for Nu Skin Enterprises’ earnings, with the lowest EPS estimate coming in at $0.93 and the highest estimate coming in at $0.98. Nu Skin Enterprises posted earnings per share of $0.76 in the same quarter last year, which would suggest a positive year over year growth rate of 26.3%. The business is scheduled to report its next quarterly earnings report after the market closes on Wednesday, November 7th.

According to Zacks, analysts expect that Nu Skin Enterprises will report full-year earnings of $3.59 per share for the current financial year, with EPS estimates ranging from $3.54 to $3.65. For the next year, analysts expect that the business will report earnings of $4.04 per share, with EPS estimates ranging from $3.76 to $4.27. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $1.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.18. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The business had revenue of $704.19 million during the quarter, compared to analysts’ expectations of $642.16 million. During the same period last year, the company posted $0.77 EPS. The company’s revenue was up 28.0% on a year-over-year basis.

A number of brokerages have recently weighed in on NUS. Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and raised their price objective for the stock from $57.00 to $70.00 in a research note on Thursday, August 2nd. They noted that the move was a valuation call. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price objective for the company in a research note on Monday, August 6th. Jefferies Financial Group set a $98.00 price objective on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Friday, August 3rd. Finally, DA Davidson assumed coverage on shares of Nu Skin Enterprises in a research note on Tuesday. They set a “buy” rating and a $92.00 price objective for the company. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $86.29.

Shares of NUS traded up $1.69 during mid-day trading on Monday, reaching $68.66. 429,264 shares of the company’s stock were exchanged, compared to its average volume of 468,632. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.82 and a quick ratio of 1.19. Nu Skin Enterprises has a 52-week low of $59.31 and a 52-week high of $88.68. The stock has a market cap of $4.58 billion, a price-to-earnings ratio of 21.26, a price-to-earnings-growth ratio of 2.35 and a beta of 1.06.

In other Nu Skin Enterprises news, President Ryan S. Napierski sold 10,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $80.00, for a total value of $800,000.00. Following the completion of the sale, the president now directly owns 74,602 shares of the company’s stock, valued at approximately $5,968,160. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel D Matthew Dorny sold 2,500 shares of Nu Skin Enterprises stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $82.18, for a total transaction of $205,450.00. Following the completion of the sale, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,783,518.78. The disclosure for this sale can be found here. Insiders sold a total of 42,850 shares of company stock valued at $3,523,563 over the last ninety days. 3.00% of the stock is owned by corporate insiders.

A number of hedge funds have recently added to or reduced their stakes in NUS. BlackRock Inc. grew its stake in Nu Skin Enterprises by 11.5% in the 2nd quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock worth $480,352,000 after acquiring an additional 635,246 shares during the period. Millennium Management LLC boosted its holdings in shares of Nu Skin Enterprises by 937.5% in the 1st quarter. Millennium Management LLC now owns 422,098 shares of the company’s stock valued at $31,113,000 after purchasing an additional 381,414 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Nu Skin Enterprises by 51.1% in the 2nd quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock valued at $63,647,000 after purchasing an additional 275,200 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Nu Skin Enterprises by 112.2% in the 2nd quarter. Acadian Asset Management LLC now owns 368,804 shares of the company’s stock valued at $28,834,000 after purchasing an additional 194,990 shares during the last quarter. Finally, OppenheimerFunds Inc. boosted its holdings in shares of Nu Skin Enterprises by 1,497.3% in the 1st quarter. OppenheimerFunds Inc. now owns 148,041 shares of the company’s stock valued at $10,912,000 after purchasing an additional 138,773 shares during the last quarter. 76.00% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Featured Story: What is an Initial Public Offering (IPO)?

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Suncor Energy  Rating Increased to Buy at GARP Research
Suncor Energy Rating Increased to Buy at GARP Research
LAIX  Coverage Initiated by Analysts at Morgan Stanley
LAIX Coverage Initiated by Analysts at Morgan Stanley
Urovant Sciences  Coverage Initiated by Analysts at Jefferies Financial Group
Urovant Sciences Coverage Initiated by Analysts at Jefferies Financial Group
Kimberly Clark  Issues FY 2018 Earnings Guidance
Kimberly Clark Issues FY 2018 Earnings Guidance
Landstar System  Research Coverage Started at Cleveland Research
Landstar System Research Coverage Started at Cleveland Research
BB&T  Given New $57.00 Price Target at BMO Capital Markets
BB&T Given New $57.00 Price Target at BMO Capital Markets


Leave a Reply

© 2006-2018 Ticker Report. Google+.